The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA–positive chronic eosinophilic leukemia
- 1 April 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (7), 2802-2805
- https://doi.org/10.1182/blood-2003-07-2479
Abstract
We recently identified the chimeric kinase FIP1L1-platelet-derived growth factor receptor α (PDGFRα) as a cause of the hypereosinophilic syndrome and of chronic eosinophilic leukemia. To investigate the role of FIP1L1-PDGFRA in the pathogenesis of acute leukemia, we screened 87 leukemia cell lines for the presence of FIP1L1-PDGFRA. One cell line, EOL-1, expressed the FIP1L1-PDGFRA fusion. Three structurally divergent kinase inhibitors—imatinib (STI-571), PKC412, and SU5614—inhibited the growth of EOL-1 cells. These results indicate that the fusion of FIP1L1 to PDGFRA occurs rarely in leukemia cell lines, but they identify EOL-1 as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and for the analysis of small molecule inhibitors of FIP1L1-PDGFRα. (Blood. 2004;103:2802-2805)Keywords
This publication has 17 references indexed in Scilit:
- Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsivenessBlood, 2003
- PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative diseaseCancer Cell, 2003
- MLL partial tandem duplications in acute leukemia cell linesLeukemia, 2003
- A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic SyndromeNew England Journal of Medicine, 2003
- FLT3 mutations in acute myeloid leukemia cell linesLeukemia, 2003
- GENETICS OF MYELOID LEUKEMIASAnnual Review of Genomics and Human Genetics, 2002
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugNature Reviews Drug Discovery, 2002
- Molecular mechanisms of leukemogenesis mediated by MLL fusion proteinsOncogene, 2001
- Continuous hematopoietic cell lines as model systems for leukemia–lymphoma researchLeukemia Research, 2000
- THE HYPEREOSINOPHILIC SYNDROMEMedicine, 1975